Long-Term Neurological Effects of COVID-19 on the Dopamine System The COVID-19 pandemic has revealed numerous ways in which the virus can impact the the brain. One area of deep concern is the long-term impact of COVID-19 on the dopamine system, which plays a crucial role in regulating mood, motivation, memory, and movement. Studies for a while have begun to uncover how SARS-CoV-2, the virus responsible for COVID-19, can affect dopamine neurons and lead to various neurological symptoms, and increase new onset ADHD. Infection and Senescence of Dopamine Neurons Research has shown that SARS-CoV-2 can infect dopamine neurons in the brain, leading to a state known as senescence. Senescence is a condition where cells lose their ability to grow and divide, which can result in significant dysfunction. Infected dopamine neurons stop producing dopamine effectively and release inflammatory signals, contributing to symptoms such as cognitive function, executive dysfunction, lethargy, and depression often observed in long COVID patients[1][2][4]. Mechanisms of Damage The infection of dopamine neurons by SARS-CoV-2 triggers several detrimental processes: - Inflammation: Infected neurons release chemical signals that cause inflammation, which can further damage brain tissue and exacerbate neurological symptoms[1][2]. - Reduced Dopamine Production: Dopamine is essential for various brain functions, including pleasure, motivation, and movement. The loss of functional dopamine neurons can lead to mood disorders and cognitive impairments[5]. - Potential Link to Parkinson's Disease: Senescence of dopamine neurons is a hallmark of Parkinson's disease. Although Parkinson's symptoms have not been widely reported in COVID-19 patients, the potential for increased risk exists and warrants further monitoring[1][4]. Neurological Symptoms in Long COVID Long COVID, a condition where symptoms persist for weeks or months after the initial infection, often includes neurological symptoms that can be linked to the impact on the dopamine system: - Brain Fog: Difficulty concentrating, processing information, and remembering things are common complaints among long COVID sufferers[3]. - Mood Disorders: Increased rates of depression and anxiety have been reported, likely due to the disruption of dopamine production[5]. - Fatigue and Sleep Disturbances: Many long COVID patients experience severe fatigue and changes in sleep patterns, which can further impact cognitive function and mood[3]. Potential Treatments and Future Directions Researchers have identified several drugs that may protect dopamine neurons from SARS-CoV-2 infection or rescue them from senescence. These include riluzole (used for ALS), metformin (used for diabetes), and imatinib (used for cancer). These drugs have shown promise in laboratory settings and may offer potential therapeutic strategies to mitigate the neurological effects of COVID-19[1][2][5]. The long-term neurological effects of COVID-19 on the dopamine system are a huge concern, with potential implications for mood disorders, cognitive impairments, and even neurodegenerative diseases like Parkinson's. Aggressive research is essential to fully understand these impacts and to develop effective treatments to protect the brain from the virus's detrimental effects. Sources [1] SARS-CoV-2 Can Infect Dopamine Neurons Causing Senescence news.weill.cornell.edu/news/… [2] COVID-19 May Infect Dopamine Neurons - Neuroscience News neurosciencenews.com/dopamin… [3] COVID-19 and the Nervous System ninds.nih.gov/current-resear… [4] SARS-CoV-2 can infect dopamine neurons causing senescence sciencedaily.com/releases/20… [5] Covid-19 makes you feel sad and moody by depleting dopamine earth.com/news/covid-19-make…
27
317
804
81,559
Replying to @Dave_it_up
David, my close friend, has developed Parkinsons disease. I believe she's had multiple Covid infections. She said the pill (not sure of the medication) hasn't helped as it has for a friend's husband. Do u know if there is a variety of treatment options or only 1 basic med?

Mar 7, 2025 · 4:09 PM UTC

4
1
54
Sort replies: Relevant Recent Liked
Replying to @ellecreative
Trial opening up!
Long COVID and viral reactivation are linked. Our latest trial focuses on repurposing existing, broad spectrum antivirals to reduce symptoms in adults with #LongCOVID. Our clinical trial is currently recruiting! Email CoreResearch@mountsinai.org to inquire.
1
1
34
The thing is, this person has not admitted to having Covid and does not have LC. She developed Parkinsons but has not mentioned any connection. There's a possibility she got it from that because her kids have had it many times, so I assume she did, too. But I can't suggest it.
1
1
19
Thank you. I'll take a listen. 😊😊
1
11
Replying to @ellecreative
There aren’t really any official medications or treatments at this time. The only ones I know people have had success with are Mabs (monoclonal, antibodies), Truvada, and Maraviroc. Everything else is pretty much symptom reduction based treatments. I would have her watch the last PolyBio seminar. If they are in NY state or NJ, Mount Sinai has the Core program that is doing studies on these.
1
1
54
That great. She is in NY. It doesn't hurt for her to have as much information as possible, and I will certainly send it to her. I really appreciate it. Thank you so much, David!!
1
1
16